The Details of the Recent Prazosin Recall

✅ No Class I, II, or III recalls of prazosin have been publicly announced by the FDA.
✅ No voluntary manufacturer-wide recalls from major generic producers (e.g., Teva, Mylan, Aurobindo, Zydus) are active.
⚠️ Isolated lot-level quality issues may occur (e.g., labeling errors, out-of-spec dissolution), but none have risen to the level of a public health alert.

📌 Note: Social media posts or news headlines sometimes misreport “recalls” based on drug shortages, discontinuations, or pharmacy inventory issues—not safety concerns.

❓ Why Might You Hear About a “Recall”?

Confusion with other medications:
- In 2023–2024, several blood pressure medications (like certain ARBs or diuretics) had recalls due to nitrosamine impurities—but prazosin was not among them.
Local pharmacy notices:
- A single pharmacy might return a batch due to storage issues (e.g., temperature exposure), but this doesn’t constitute an official recall.
Misinformation online:
- AI-generated or sensationalized content sometimes fabricates “recalls” to drive clicks.

✅ How to Verify a Recall (If You’re Concerned)

Check your prescription bottle: Note the NDC number, lot number, and manufacturer.
Search the FDA’s Recall Database:
→ https://www.fda.gov/safety/recalls
Visit the manufacturer’s website (e.g., Teva, Mylan).
Call your pharmacist—they receive real-time recall alerts.

⚠️ What If You’re Taking Prazosin?

Do not stop taking it abruptly, especially if used for blood pressure or PTSD—this can cause dangerous rebound effects.
If you’re concerned about your supply, talk to your doctor or pharmacist.
Generic prazosin remains widely available and considered safe when used as prescribed.